>Mercado Europeu de Vacinas, por Composição (Vacinas Combinadas, Monovacinas), Tipo (Vacinas de Subunidade, Recombinantes, Polissacarídeos e Conjugadas, Vacinas Vivas Atenuadas, Vacinas Inactivadas, Vacinas Toxóides, Vacinas de ADN), Tipo (Vacina de Rotina, Vacina Recomendada, Vacina Obrigatória ), Idade de administração (vacina pediátrica, vacina para adultos), doenças (doença pneumocócica, sarampo, papeira e varicela, DPT, hepatite, gripe, febre tifóide, meningocócica, raiva, encefalite japonesa, febre amarela, outras), via de administração (injetável , Oral, Nasal), Utilizador Final (Hospitais Comunitários, Hospitais, Centros Especializados, Clínicas, Outros), Canal de Distribuição (Farmácia Hospitalar, Farmácia de Retalho, Farmácia Online), País (Alemanha, Reino Unido, França, Itália, Espanha, Holanda, Rússia , Suíça, Turquia, Áustria, Noruega, Hungria, Lituânia, Irlanda, Polónia e Resto da Europa) Tendências e previsões da indústria para 2028
Análise e insights de mercado: Mercado de vacinas na Europa
Espera-se que o mercado europeu de vacinas ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 6,5% no período de previsão de 2021 a 2028 e deverá atingir os 61.988,47 milhões de dólares até 2028. A elevada prevalência de condições crónicas, como a gripe e as doenças infeciosas bacterianas, e o lançamento de vacinas mais recentes são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.
As vacinas compreendem características que a crescente necessidade de produtos seguros e eficazes terá impacto no lançamento de novos produtos pelos fabricantes no mercado que aumentam a sua procura, bem como o aumento do investimento em investigação e desenvolvimento leva ao crescimento do mercado. Estão actualmente a ser realizados vários estudos de investigação que deverão criar uma vantagem competitiva para os fabricantes desenvolverem produtos de vacinas novos e inovadores, o que deverá proporcionar várias outras oportunidades no mercado das vacinas. No entanto, as dificuldades associadas ao transporte e produção de vacinas e o receio entre os doentes relacionados com injecções e picadas de agulhas deverão restringir o crescimento do mercado no período de previsão.
As vacinas são a preparação biológica que fornece imunidade adquirida ativa contra uma doença específica. A vacina contém uma substância ou agentes que se assemelham a microrganismos causadores de doenças e é preparada no fim de semana ou forma morta de agentes patogénicos, como bactérias ou vírus. Quando são injetados agentes patogénicos enfraquecidos ou mortos num corpo, estes micróbios fazem com que as células B, que são células de memória do sistema imunitário, reconheçam o agente patogénico e, no futuro, se o mesmo agente patogénico atacar o corpo, atuará contra eles. Foram descobertas vacinas para vários tipos de doenças infecciosas predominantes, incluindo doenças pneumocócicas, sarampo, papeira, rubéola, hepatite, gripe, febre tifóide, varicela, raiva, entre outras.
O relatório de mercado de vacinas fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos , decisões estratégicas, lançamentos de produtos, geografia expansões e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Âmbito e dimensão do mercado global de vacinas
O mercado das vacinas está categorizado em oito segmentos notáveis que se baseiam na composição, tipo, tipo, idade de administração, doenças, via de administração, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
- Com base na composição, o mercado das vacinas está segmentado em vacinas combinadas, monovacinas. Em 2021, o segmento das vacinas combinadas está a dominar o mercado porque uma única vacina combinada pode ser utilizada para a prevenção de diferentes tipos de doenças.
- Com base no tipo, o mercado das vacinas está segmentado em vacinas subunitárias, recombinantes, polissacáridas e conjugadas , vacinas vivas atenuadas, vacinas inativadas , vacinas toxóides e vacinas de ADN. Em 2021, o segmento das vacinas de subunidades, recombinantes, polissacáridas e conjugadas está a dominar o mercado porque estas vacinas podem ser utilizadas por quase todas as pessoas, de modo a aumentar a resposta imunitária. Além disso, o aumento dos investimentos das empresas e o aumento do apoio governamental ao desenvolvimento de novas vacinas estão a funcionar como outro factor para acelerar o crescimento do mercado.
- Com base no tipo, o mercado das vacinas está segmentado em vacina de rotina, vacina recomendada e vacina necessária. Em 2021, o segmento das vacinas de rotina está a dominar o mercado porque os profissionais de saúde e as autoridades governamentais estão altamente focados na vacinação infantil, de modo a quebrar o ciclo intergeracional da pobreza.
- Com base na idade de administração, o mercado das vacinas está segmentado em vacinas pediátricas e vacinas para adultos. Em 2021, o segmento das vacinas pediátricas está a dominar o mercado devido ao crescente lançamento do programa de imunização e da campanha de vacinação infantil.
- Com base nas doenças, o mercado das vacinas está segmentado em doenças pneumocócicas, sarampo, papeira e varicela, DPT, hepatite, gripe, febre tifóide, meningocócica, raiva, encefalite japonesa , febre amarela e outras. Em 2021, o segmento das doenças pneumocócicas está a dominar o mercado devido ao aumento da prevalência da infeção por pneumonia, mais comum em crianças e também reportada como afetando uma grande população de adultos.
- On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal. In 2021, injectable segment is dominating the market because vaccines administered via parenteral route provide long term systemic response in a controlled release manner.
- On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics and others. In 2021, community hospitals segment is dominating the market because of increasing government focus on vaccination and increasing campaign launch for mass vaccination.
- On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy segment is dominating the market because most of the people visit community hospitals and hospital who used to procure vaccines directly from nearby hospital pharmacy.
Vaccines Market Country Level Analysis
The vaccines market is analyzed and market size information is provided on the basis of the composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel.
The countries covered in the vaccines market report are Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe.
Routine vaccine segment in Europe region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing clinical trials and research development for prevention of flu related diseases among the children. Germany is leading the growth of the Asia-Pacific market and routine vaccine segment is dominating in this country due to increased consumption and production of vaccines. U.K. is the fastest growing country because rising government initiative for the vaccination.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Presence of Pipeline Products and Increasing Awareness for Vaccination are Boosting the Market Growth of Vaccines
Vaccines market also provides you with detailed market analysis for every country growth in Vaccines industry with Vaccines drugs sales, impact of advancement in the Vaccines technology and changes in regulatory scenarios with their support for the Vaccines market. The data is available for historic period 2010 to 2019.
Análise do cenário competitivo e da quota de mercado das vacinas
O panorama competitivo do mercado de vacinas fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto e respiração, domínio da aplicação, curva da linha de vida da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa relacionado com o mercado de Vacinas.
As principais empresas que negoceiam vacinas são a Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Merck Sharp & Dohme Corp. (uma subsidiária da Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (Uma subsidiária da CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC (uma subsidiária da Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, ALK, Panacea Biotec Ltd, BAXTER VACCINES (uma subsidiária da Baxter), GlaxoSmithKline plc., Serum Institute of India Pvt., entre outros.
Muitos lançamentos e acordos de produtos são também iniciados por empresas de todo o mundo, que também estão a acelerar o mercado das vacinas.
- Em agosto de 2020, a Bavarian Nordic lançou a vacina RABAVERT nos EUA. A vacina RABAVERT está indicada para a vacinação da população de todas as idades. Esta iniciativa ajudou a empresa a alcançar um crescimento rentável no mercado das vacinas.
- Em julho de 2020, a Dynavax Technologies colaborou com a Mount Sinai para o desenvolvimento de uma vacina universal contra a gripe. De acordo com a colaboração, o Mount Sinai utilizará o adjuvante CpG fabricado pela Dynavax Technologies Corporation para o desenvolvimento de novas vacinas. Para o desenvolvimento da nova vacina, o Mount Sinai irá produzir hemaglutinina quimérica (cHA) concebida para proteger contra todas as diferentes estirpes de influenza. Esta iniciativa impulsionou a receita da empresa ao fornecer a sua plataforma proprietária para o desenvolvimento de novas vacinas
A colaboração, o lançamento de produtos, a expansão do negócio, a premiação e reconhecimento, as joint ventures e outras estratégias do player de mercado estão a potenciar o mercado da empresa no mercado das Vacinas, o que também proporciona o benefício para a organização melhorar a sua oferta de Vacinas.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of EUROPE vaccines MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- composition LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insight
- epidemiology
- Pipeline analysis
- Europe VACCINES Market: Laws and regulations
- Europe VACCINES Market: logistics of vaccines
- Cold Chain Storage:
- Regulations Associated With Vaccine Supply
- Process of Logistics
- CHALLENGES IN LOGISTICS
- Challenges faced by India for upcoming COVID 19 Vaccine:
- Challenges faced by Latin America for upcoming vaccine:
- Challenges Faced by Nigeria for vaccine logistics:
- Market Overview
- Drivers
- growing immunization programs and campaigns
- HIGH PREVALENCE OF CHRONIC CONDITION SUCH AS FLU AND BACTERIAL INFECTIOUS DISEAsES
- IMPROVEMENT IN TREATMENT
- launch of newer vaccines
- increasing government support
- RESTRAINTS
- UNAVAILABILITY OF REGISTERED VACCINES
- HIGH COST AND DIFFERENCES IN PRICING OF THE VACCINES
- DIFFICULTIES ASSOCIATED WITH TRANSPORT AND PRODUCTION OF VACCINES
- opportunities
- STRATEGIC INITIATIVES BY the MARKET PLAYERS
- presence of pipeline products
- Rise in expenditure in healthcare sector
- increasing awareness for vaccination
- challenges
- Side Effects Caused by Vaccines
- fear among patients related to injections and needle sticks
- product recall
- Impact of COVID-19 on Europe Vaccines Market
- PRICE IMPACT
- IMPACT ON SUPPLY CHAIN
- IMPACT ON DEMAND
- CONCLUSION
- Europe vaccines MARKET, BY composition
- overview
- COMBINATION VACCINES
- MONO VACCINES
- Europe vaccines MARKET, BY type
- overview
- SUBUNIT, RECOMBINANT, POLYSACCHARIDE, AND CONJUGATE VACCINES
- Pneumococcal Disease
- HIB (Haemophilus Influenzae Type B) Disease
- HPV (Human Papilloma Virus)
- Hepatitis B
- Meningococcal
- Shingles
- Whooping Cough
- OTHERS
- LIVE-ATTENUTAED VACCINES
- Rotavirus
- Measles
- mumps
- Rubella
- SMALLPOX
- yellow fever
- OTHERS
- INACTIVATED VACCINES
- Flu (Shot Only)
- Polio (Shot Only)
- Hepatitis A
- Rabies
- Others
- TOXOID VACCINES
- diphtheria, Tetanus & Pertussis (DTP)
- Others
- DNA VACCINES
- Europe vaccines MARKET, BY kind
- overview
- ROUTINE VACCINE
- PNEUMOCOCCAL
- DIPHTHERIA
- HIB (Haemophilus Influenzae Type B) Disease
- MEASLES
- MUMPS
- HEPATITIS B
- RUBELLA
- POLIO
- OTHERS
- RECOMMENDED VACCINES
- TYPHOID FEVER VACCINES
- HEPATITIS A
- RABIES
- JAPANESE ENCEPHALITIS
- TICK-BORNE ENCEPHALITIS
- CHOLERA
- OTHERS
- REQUIRED VACCINES
- Meningococcal
- Yellow Fever
- Others
- Europe vaccines MARKET, BY Age of Administration
- overview
- PEDIATRIC VACCINES
- PNEUMOCOCCAL
- MEASLES, MUMPS, AND, RUBELLA
- Diphtheria, Tetanus & Pertusis (DPT)
- ROTAVIRUS
- MENINGOCOCCAL
- VARICELLA
- POLIO
- TUBERCULOSIS
- malaria
- OTHERS
- ADULT VACCINES
- inlfuenza
- HPV (Human Papilloma Virus)
- Typhoid
- Hepatitis B
- Japanese Encephalitis
- YELLOW FEVER
- HIV
- CANCER
- OTHERS
- Europe vaccines MARKET, BY diseases
- overview
- pneumoccocal disease
- Measles, Mumps & Rubella
- DPT
- hepatitis
- Influenza
- Typhoid
- Meningococcal
- Varicella
- Rabies
- Japanese Encephalitis
- Yellow Fever
- others
- Europe vaccines MARKET, BY route of administration
- overview
- INJECTABLE
- Intramuscular
- Subcutaneous
- Intradermal
- ORAL
- NASAL
- Europe vaccines MARKET, BY end user
- overview
- COMMUNITY HOSPITALS
- HOSPITALS
- SPECIALTY CENTRES
- CLINICS
- OTHERS
- Europe vaccines MARKET, BY distribution channel
- overview
- HOSPITAL PHARMACy
- RETAIL PHARMACy
- ONLINE PHARMACy
- EUROPE vaccines MARKET, by Geography
- EUROPE
- germany
- france
- U.K.
- italy
- spain
- NETHERLAND
- russia
- Switzerland
- TURKEY
- Austria
- norway
- hungary
- lithuania
- Ireland
- poland
- rest of europe
- Europe Vaccines Market: COMPANY landscape
- company share analysis: europe
- company profile
- glaxosmithkline plc.
- COMPANY SNAPSHOt
- revenue analysis
- company share analysis
- product portfolio
- recent developmentS
- swot analysis
- Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analys
- Sanofi
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analys
- Pfizer Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- pRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot anal
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- company share analysis
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ALK
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Altimmune
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- AstraZeneca
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bavarian Nordic
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BAXTER VACCINES (A Subsidiary of Baxter)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- BHARAT BIOTECH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Bio Farma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biological E Limited
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- DAIICHI SANKYO COMPANY, LIMITED
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Dynavax Technologies
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Emergent BioSolutions Inc.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Janssen Europe Services, LLC (A Subsidiary of Johnson & Johnson Services, Inc.)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- lanzhou biological products research institute co., ltd.,
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Panacea Biotec Ltd
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Seqirus (A Subsidiary of CSL Limited)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- swot analysis
- serum institute of india pvt. ltd.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Takeda Pharmaceutical Company Limited
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Valneva SE
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Lista de Tabela
TABLE 1 Europe vaccines Market, pipeline analysis
TABLE 2 REGULATIONS IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS
TABLE 3 Recommended Temperature and Storage Length At Various Level of The Cold Chain.
TABLE 4 PROCEDURES for reporting to Unicef vaccine arrivals.
TABLE 5 logisitcs process acorss different regions.
TABLE 6 the u.s. funding for gavi (2015-2019)
TABLE 7 Price of the vaccines between the U.S. and developing countries
TABLE 8 vaccines under clinical trial
TABLE 9 the side effects related to the vaccines
TABLE 10 INCREASE IN OPERATIONAL COST COMPONENTS DUE TO COVID-19
TABLE 11 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES
TABLE 12 Europe Vaccines Market, By Composition, 2019-2028 (USD Million)
TABLE 13 Europe Combination Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 14 Europe Mono Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 15 Europe Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 16 Europe Subunit, Recombinant, Polysaccharide & Conjugated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 17 Europe Live-Attenuated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 18 Europe Live-Attenuated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 19 Europe Inactivated Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 20 Europe Inactivated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 21 Europe Toxoid Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 22 Europe Toxoid Vaccines in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 23 Europe vaccines Market, By kind, 2019-2028 (USD Million)
TABLE 24 Europe Routine Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 25 Europe Routine Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 26 Europe Recommended Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 27 Europe Recommended Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 28 Europe Required Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 29 Europe Required Vaccine in Vaccines Market, By Kind, 2019-2028 (USD Million)
TABLE 30 Europe Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 31 Europe Pediatric Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 32 Europe Pediatric Vaccine in Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 33 Europe Adult Vaccine in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 34 Europe Adult in Vaccines Market, By Age of Administration, 2019-2028 (USD Million)
TABLE 35 Europe pneumococcal disease in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 36 Europe measles, mumps & rubella in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 37 Europe DPT in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 38 Europe hepatitis in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 39 Europe influenza in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 40 Europe typhoid in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 41 Europe meningococcal in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 42 Europe varicella in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 43 Europe rabies in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 44 Europe Japanese encephalitis in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 45 Europe yellow fever in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 46 Europe other in vaccines Market, By Region, 2017-2028 (USD Million)
TABLE 47 Europe Vaccines Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 48 Europe Injectable in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 49 Europe Injectable in Vaccines Market, By Route of Administration, 2019-2028 (USD Million)
TABLE 50 Europe Oral in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 51 Europe Nasal in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 52 Europe Vaccines Market, By End User, 2019-2028 (USD Million)
TABLE 53 Europe Community Hospitals in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 54 Europe Hospitals in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 55 Europe Specialty Centres in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 56 Europe Clinics in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 57 Europe others in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 58 Europe Vaccines Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 59 Europe Hospital Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 60 Europe Retail Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 61 Europe Online Pharmacy in Vaccines Market, By Region, 2019-2028 (USD Million)
TABLE 62 EUROPE VACCINES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 63 EUROPE VACCINES Market, By COMPOSITION, 2019-2028 (USD Million)
TABLE 64 EUROPE VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 65 EUROPE Subunit, Recombinant, Polysaccharide & Conjugated Vaccines in vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 66 EUROPE Live-Attenuated Vaccines in Vaccines Market, By Type, 2019-2028 (USD Million)
TABLE 67 EUROPE Inactivated Vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 68 EUROPE Toxoid Vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 69 EUROPE VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 70 EUROPE Routine Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 71 EUROPE Recommended Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 72 EUROPE Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 73 EUROPE VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 74 EUROPE pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 75 EUROPE adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 76 EUROPE VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 77 EUROPE VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 78 EUROPE injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 79 EUROPE VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 80 EUROPE VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 81 GERMANY VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 82 GERMANY VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 83 GERMANY subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 84 GERMANY live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 85 GERMANY inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 86 GERMANY toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 87 GERMANY VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 88 GERMANY routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 89 GERMANY recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 90 GERMANY Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 91 GERMANY VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 92 GERMANY pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 93 GERMANY adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 94 GERMANY VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 95 GERMANY VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 96 GERMANY VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 97 GERMANY VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 98 GERMANY injectable in VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 99 FRANCE VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 100 FRANCE VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 101 FRANCE subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 102 FRANCE live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 103 FRANCE inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 104 FRANCE toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 105 FRANCE VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 106 FRANCE routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 107 FRANCE recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 108 FRANCE Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 109 FRANCE VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 110 FRANCE pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 111 FRANCE adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 112 FRANCE VACCINES Market, By disease, 2019-2028 (USD Million)
TABLE 113 FRANCE VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 114 FRANCE injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 115 FRANCE VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 116 FRANCE VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 117 U.K. VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 118 U.K. VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 119 U.K. subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 120 U.K. live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 121 U.K. inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 122 U.K. toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 123 U.K. VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 124 U.K. routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 125 U.K. recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 126 U.K. Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 127 U.K. VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 128 U.K. pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 129 U.K. adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 130 U.K. VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 131 U.K. vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 132 U.K. injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 133 U.K. VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 134 U.K. VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 135 italy VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 136 italy VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 137 ITALY subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 138 ITALY live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 139 ITALY inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 140 ITALY toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 141 italy VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 142 ITALY routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 143 italy recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 144 italy Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 145 italy VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 146 italy pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 147 italy adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 148 italy VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 149 italy vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 150 italy injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 151 italy VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 152 italy VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 153 spain VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 154 SPAIN VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 155 SPAIN subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 156 SPAIN live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 157 SPAIN inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 158 SPAIN toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 159 SPAIN VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 160 SPAIN routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 161 SPAIN recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 162 SPAIN Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 163 SPAIN VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 164 SPAIN pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 165 SPAIN adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 166 SPAIN VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 167 SPAIN vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 168 SPAIN injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 169 SPAIN VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 170 SPAIN VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 171 NETHERLAND VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 172 netherland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 173 netherland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 174 netherland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 175 netherland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 176 netherland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 177 netherland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 178 netherland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 179 netherland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 180 netherland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 181 netherland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 182 netherland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 183 netherland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 184 netherland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 185 netherland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 186 netherland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 187 NETHERLAND VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 188 NETHERLAND VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 189 russia VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 190 russia VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 191 russia subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 192 russia live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 193 russia inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 194 russia toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 195 russia VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 196 russia routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 197 russia recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 198 russia Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 199 russia VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 200 russia pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 201 russia adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 202 russia VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 203 russia vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 204 russia injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 205 russia VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 206 russia VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 207 Switzerland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 208 Switzerland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 209 Switzerland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 210 Switzerland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 211 Switzerland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 212 Switzerland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 213 Switzerland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 214 Switzerland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 215 Switzerland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 216 Switzerland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 217 Switzerland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 218 Switzerland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 219 Switzerland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 220 Switzerland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 221 Switzerland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 222 Switzerland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 223 Switzerland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 224 Switzerland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 225 turkey VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 226 turkey VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 227 turkey subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 228 turkey live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 229 turkey inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 230 turkey toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 231 turkey VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 232 turkey routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 233 turkey recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 234 turkey Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 235 turkey VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 236 turkey pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 237 turkey adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 238 turkey VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 239 turkey vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 240 turkey injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 241 turkey VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 242 turkey VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 243 austria VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 244 austria VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 245 austria subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 246 austria live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 247 austria inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 248 austria toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 249 austria VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 250 austria routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 251 austria recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 252 austria Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 253 austria VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 254 austria pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 255 austria adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 256 austria VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 257 austria vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 258 austria injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 259 austria VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 260 austria VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 261 Norway VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 262 norway VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 263 norway subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 264 norway live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 265 norway inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 266 norway toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 267 norway VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 268 norway routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 269 norway recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 270 norway Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 271 norway VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 272 norway pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 273 norway adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 274 norway VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 275 norway vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 276 norway injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 277 norway VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 278 norway VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 279 hungary VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 280 hungary VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 281 hungary subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 282 hungary live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 283 hungary inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 284 hungary toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 285 hungary VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 286 hungary routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 287 hungary recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 288 hungary Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 289 hungary VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 290 hungary pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 291 hungary adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 292 hungary VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 293 hungary vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 294 hungary injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 295 hungary VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 296 hungary VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 297 Lithuania VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 298 Lithuania VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 299 Lithuania subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 300 Lithuania live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 301 Lithuania inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 302 Lithuania toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 303 Lithuania VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 304 Lithuania routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 305 Lithuania recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 306 Lithuania Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 307 Lithuania VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 308 Lithuania pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 309 Lithuania adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 310 Lithuania VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 311 Lithuania vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 312 Lithuania injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 313 Lithuania VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 314 Lithuania VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 315 ireland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 316 ireland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 317 ireland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 318 ireland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 319 ireland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 320 ireland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 321 ireland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 322 ireland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 323 ireland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 324 ireland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 325 ireland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 326 ireland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 327 ireland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 328 ireland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 329 ireland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 330 ireland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 331 ireland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 332 Ireland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 333 poland VACCINES Market, By composition, 2019-2028 (USD Million)
TABLE 334 poland VACCINES Market, By Type, 2019-2028 (Usd million)
TABLE 335 poland subunit, recombinant, polysaccharide & conjugated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 336 poland live-attenuated vaccines in VACCINES Market, By Type, 2019-2028 (USD Million)
TABLE 337 poland inactivated vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 338 poland toxoid vaccines in VACCINES Market, By type, 2019-2028 (USD Million)
TABLE 339 poland VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 340 poland routine vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 341 poland recommended vaccines in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 342 poland Required Vaccine in VACCINES Market, By kind, 2019-2028 (USD Million)
TABLE 343 poland VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 344 poland pediatric Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 345 poland adult Vaccine in VACCINES Market, By age of administration, 2019-2028 (USD Million)
TABLE 346 poland VACCINES Market, By diseases, 2019-2028 (USD Million)
TABLE 347 poland vACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 348 poland injectable in VACCINES Market, By route of administration, 2019-2028 (USD Million)
TABLE 349 poland VACCINES Market, By end user, 2019-2028 (USD Million)
TABLE 350 poland VACCINES Market, By Distribution channel, 2019-2028 (USD Million)
TABLE 351 rest of europe VACCINES Market, By composition, 2019-2028 (USD Million)
Lista de Figura
FIGURE 1 Europe VACCINES MARKET: SEGMENTATION
FIGURE 2 EUROPE VACCINES MARKET : DATA TRIANGULATION
FIGURE 3 Europe Vaccines Market: DROC ANALYSIS
FIGURE 4 Europe Vaccines market: Europe VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe Vaccines Market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Vaccines MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE Vaccines MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE VACCINES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE VACCINES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 Europe Vaccines market: SEGMENTATION
FIGURE 11 Growing Immunization Programs and Campaigns and High Prevalence of Chronic Condition such as Flu and Bacterial Infectious Diseases are DRIVing THE Europe Vaccines MARKET IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 12 combination vaccines SEGMENT is expected to account for the largest share of the Europe VACCINES MARKET in 2021 & 2028
FIGURE 13 FDA Regulatory Review Process of Vaccines
FIGURE 14 AEFI ORGANIZATIONAL STRUCTURES
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE vaccines market
FIGURE 16 Europe vaccination coverage in the world (2019)
FIGURE 17 Pediatric deaths caused by influenza in the U.S. (2017 – 2020)
FIGURE 18 Europe prevalence of hbv infection worldwide in 2018
FIGURE 19 Healthcare expenditure per capita, 2018
FIGURE 20 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES
FIGURE 21 Europe vaccines market: BY composition, 2021
FIGURE 22 Europe vaccines market: BY composition, 2019-2028 (USD Million)
FIGURE 23 Europe vaccines market: BY composition, CAGR (2021-2028)
FIGURE 24 Europe vaccines market: BY composition, LIFELINE CURVE
FIGURE 25 Europe vaccines market: BY type, 2021
FIGURE 26 Europe vaccines market: BY type, 2019-2028 (USD Million)
FIGURE 27 Europe vaccines market: BY type, CAGR (2021-2028)
FIGURE 28 Europe vaccines market: BY type, LIFELINE CURVE
FIGURE 29 Europe vaccines market: BY kind, 2019
FIGURE 30 Europe vaccines market: BY kind, 2019-2028 (USD Million)
FIGURE 31 Europe vaccines market: BY kind, CAGR (2021-2028)
FIGURE 32 Europe vaccines market: BY kind, LIFELINE CURVE
FIGURE 33 Europe vaccines market: BY age of administration, 2019
FIGURE 34 Europe vaccines market: BY age of administration, 2019-2028 (USD Million)
FIGURE 35 Europe vaccines market: BY age of administration, CAGR (2021-2028)
FIGURE 36 Europe vaccines market: BY age of administration, LIFELINE CURVE
FIGURE 37 Europe vaccines market: BY diseases, 2020
FIGURE 38 Europe vaccines market: BY diseases, 2019-2028 (USD Million)
FIGURE 39 Europe vaccines market: BY diseases, CAGR (2021-2028)
FIGURE 40 Europe vaccines market: BY diseases, LIFELINE CURVE
FIGURE 41 Europe vaccines market: BY route of administration, 2019
FIGURE 42 Europe vaccines market: BY route of administration, 2019-2028 (USD Million)
FIGURE 43 Europe vaccines market: BY route of administration, CAGR (2021-2028)
FIGURE 44 Europe vaccines market: BY route of administration, LIFELINE CURVE
FIGURE 45 Europe vaccines market: BY end user, 2019
FIGURE 46 Europe vaccines market: BY end user, 2019-2028 (USD Million)
FIGURE 47 Europe vaccines market: BY end user, CAGR (2021-2028)
FIGURE 48 Europe vaccines market: BY end user, LIFELINE CURVE
FIGURE 49 Europe vaccines market: BY distribution channel, 2019
FIGURE 50 Europe vaccines market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 51 Europe vaccines market: BY distribution channel, CAGR (2021-2028)
FIGURE 52 Europe vaccines market: BY distribution channel, LIFELINE CURVE
FIGURE 53 EUROPE VACCINES market: SNAPSHOT (2020)
FIGURE 54 EUROPE VACCINES market: BY COUNTRY (2020)
FIGURE 55 EUROPE VACCINES market: BY COUNTRY (2021 & 2028)
FIGURE 56 EUROPE VACCINES market: BY COUNTRY (2020 & 2028)
FIGURE 57 EUROPE VACCINES market: BY type (2021-2028)
FIGURE 58 EUROPE Vaccines Market: company share 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
